| Line item | 2026-05-31 FY | 2025-05-31 FY | 2024-05-31 FY | 2023-05-31 FY | 2022-05-31 FY | 2021-05-31 FY |
|---|---|---|---|---|---|---|
| Revenue | $94.72B | $87.93B | $87.69B | $90.16B | $93.51B | $83.96B |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – | – |
| R&D | – | – | – | – | – | – |
| SG&A | – | – | – | – | – | – |
| Operating Income | $5.46B | $5.22B | $5.56B | $4.91B | $6.25B | $5.86B |
| Interest Expense | – | – | $745.00M | $694.00M | $689.00M | $793.00M |
| Tax Expense | $1.36B | $1.35B | $1.50B | $1.39B | $1.07B | $1.44B |
| Net Income | $4.43B | $4.09B | $4.33B | $3.97B | $3.83B | $5.23B |
| EPS (basic) | 18.7100 | 16.9600 | 17.4100 | 15.6000 | 14.5400 | 19.7900 |
| EPS (diluted) | 18.5500 | 16.8100 | 17.2100 | 15.4800 | 14.3300 | 19.4500 |
| Shares (diluted) | $239.00M | $243.00M | $251.00M | $256.00M | $266.00M | $268.00M |